2014 -- S 2801 | |
======== | |
LC005176 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2014 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE - INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE USE DISORDERS | |
| |
Introduced By: Senators Jabour, Miller, Satchell, Cool Rumsey, and Pichardo | |
Date Introduced: March 25, 2014 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 27-38.2-1 of the General Laws in Chapter 27-38.2 entitled |
2 | "Insurance Coverage for Mental Illness and Substance Abuse" is hereby amended to read as |
3 | follows: |
4 | 27-38.2-1. Mental illness coverage. -- Mental illness and substance abuse coverage. -- |
5 | (a) Every health care insurer that delivers or issues for delivery or renews in this state a contract, |
6 | plan, or policy except contracts providing supplemental coverage to Medicare or other |
7 | governmental programs, shall provide coverage for the medical treatment of mental illness and |
8 | substance abuse under the same terms and conditions as that coverage is provided for other |
9 | illnesses and diseases. Insurance coverage offered pursuant to this statute must include the same |
10 | durational limits, amount limits, deductibles, and co-insurance factors for mental illness as for |
11 | other illnesses and diseases. |
12 | (b) In addition to the requirements of subsection (a), every healthcare insurer that delivers |
13 | or issues for delivery or renews in this state a contract, plan, or policy, except contracts providing |
14 | supplemental coverage to Medicare or other governmental programs, shall also provide |
15 | prescription drug coverage for: |
16 | (1) Anti-opioid and anti-opiate drugs, including, but not limited to, narcan and other |
17 | forms of naloxone for use of intervention in opioid overdoses; |
18 | (2) Drugs used for the treatment of substance use disorders, including, but not limited to, |
| |
1 | methadone, suboxone, naltrexone, and buprenorphine; and |
2 | (3) Provided, the prescription drug coverage pursuant to subsection (b) of this section |
3 | shall be under the same terms and conditions as that coverage is provided for other illnesses and |
4 | diseases. Insurance coverage offered pursuant to subsection (b) of this section must include the |
5 | same durational limits, amount limits, deductibles, and co-insurance factors for mental illness as |
6 | for other illnesses and diseases. |
7 | SECTION 2. Sections 23-17.26-2 and 23-17.26-3 of the General Laws in Chapter 23- |
8 | 17.26 entitled "Comprehensive Discharge Planning" are hereby amended to read as follows: |
9 | 23-17.26-2. Definitions. -- As used in this chapter: |
10 | (1) "Director" means the director of department of health. |
11 | (2) "Department" means the department of health. |
12 | (3) "Hospital" means a person or governmental entity licensed in accordance with |
13 | chapter 17 of this title to establish, maintain and operate a hospital. |
14 | (4) "Health care clinic" means a health care facility licensed in accordance with chapter |
15 | 17 of this title and which primarily delivers ambulatory care on an out-patient basis. |
16 | (5) "Urgent care center" means a health care facility licensed in accordance with chapter |
17 | 17 of this title that primarily provides emergent health care services and urgent health care |
18 | services as defined in § 23-17.12-2. |
19 | (6) "Emergency room diversion facility" means a health care facility approved by the |
20 | Rhode Island department of behavioral healthcare, developmental disabilities and hospitals to act |
21 | as an immediate alternative to a hospital or emergency room, and which concentrates on treating |
22 | non-urgent substance use disorders that can be appropriately treated in alternative settings. |
23 | 23-17.26-3. Comprehensive discharge planning. -- (a) On or before July 1, 2015, each |
24 | hospital, health care clinic, and urgent care center and emergency room diversion facility, |
25 | sometimes collectively referred to herein as the "health care facility," operating in the State of |
26 | Rhode Island shall submit to the director: |
27 | (1) Evidence of participation in a high-quality comprehensive discharge planning and |
28 | transitions improvement project operated by a nonprofit organization in this state; or |
29 | (2) A plan for the provision of comprehensive discharge planning and information to be |
30 | shared with patients transitioning from the hospitals care. Such plan shall contain the adoption of |
31 | evidence-based practices including, but not limited to: |
32 | (i) Providing in-hospital education prior to discharge; |
33 | (ii) Ensuring patient involvement such that, at discharge, patients, and caregivers |
34 | understand the patient's conditions and medications and have a point of contact for follow-up |
| LC005176 - Page 2 of 10 |
1 | questions; |
2 | (iii) Attempting to identify patients' primary care providers and assisting with scheduling |
3 | post-hospital follow-up appointments prior to patient discharge; |
4 | (iv) Expanding the transmission of the department of health's continuity of care form, or |
5 | successor program, to include primary care providers' receipt of information at patient discharge |
6 | when the primary care provider is identified by the patient; and |
7 | (v) Coordinating and improving communication with outpatient providers. |
8 | (3) Until March 1, 2018, such discharge plan and transition process shall also be made for |
9 | patients with opioid and other substance use disorders, which plan and transition process shall |
10 | include all the elements contained in subsections (a)(1) or (a)(2) of this section as applicable. In |
11 | addition, such discharge plan and transition process shall also include: |
12 | (i) A requirement that there be a follow-up contact made with the patient within thirty |
13 | (30) days post-discharge from the health care facility to assess the patient's progress; |
14 | (ii) A requirement that at least one follow-up appointment be scheduled for the patient |
15 | within seven (7) days of discharge, either at the same health care facility, or at another |
16 | appropriate facility. Said appointment shall be scheduled and the patient shall be informed of the |
17 | appointment prior to the patient being discharged from the hospital; and |
18 | (iii) A requirement that the patient receive information about the real-time availability of |
19 | in-patient and out-patient services. |
20 | (4) On or before January 1, 2015, the director of the department of health shall develop |
21 | and disseminate to all hospitals, health care clinics, urgent care centers, and emergency room |
22 | diversion facilities a model discharge plan and transition process for patients with opioid and |
23 | other substance use disorders. This model plan may be used as a guide, but may be amended and |
24 | modified to meet the specific needs of each hospital, health care clinic, urgent care center and |
25 | emergency room diversion facility. |
26 | SECTION 3. Section 42-14.5-3 of the General Laws in Chapter 42-14.5 entitled "The |
27 | Rhode Island Health Care Reform Act of 2004 - Health Insurance Oversight" is hereby amended |
28 | to read as follows: |
29 | 42-14.5-3. Powers and duties [Contingent effective date; see effective dates under |
30 | this section.] -- The health insurance commissioner shall have the following powers and duties: |
31 | (a) To conduct quarterly public meetings throughout the state, separate and distinct from |
32 | rate hearings pursuant to section 42-62-13, regarding the rates, services and operations of insurers |
33 | licensed to provide health insurance in the state the effects of such rates, services and operations |
34 | on consumers, medical care providers, patients, and the market environment in which such |
| LC005176 - Page 3 of 10 |
1 | insurers operate and efforts to bring new health insurers into the Rhode Island market. Notice of |
2 | not less than ten (10) days of said hearing(s) shall go to the general assembly, the governor, the |
3 | Rhode Island Medical Society, the Hospital Association of Rhode Island, the director of health, |
4 | the attorney general and the chambers of commerce. Public notice shall be posted on the |
5 | department's web site and given in the newspaper of general circulation, and to any entity in |
6 | writing requesting notice. |
7 | (b) To make recommendations to the governor and the house of representatives and |
8 | senate finance committees regarding health care insurance and the regulations, rates, services, |
9 | administrative expenses, reserve requirements, and operations of insurers providing health |
10 | insurance in the state, and to prepare or comment on, upon the request of the governor, or |
11 | chairpersons of the house or senate finance committees, draft legislation to improve the regulation |
12 | of health insurance. In making such recommendations, the commissioner shall recognize that it is |
13 | the intent of the legislature that the maximum disclosure be provided regarding the |
14 | reasonableness of individual administrative expenditures as well as total administrative costs. The |
15 | commissioner shall make recommendations on the levels of reserves including consideration of: |
16 | targeted reserve levels; trends in the increase or decrease of reserve levels; and insurer plans for |
17 | distributing excess reserves. |
18 | (c) To establish a consumer/business/labor/medical advisory council to obtain |
19 | information and present concerns of consumers, business and medical providers affected by |
20 | health insurance decisions. The council shall develop proposals to allow the market for small |
21 | business health insurance to be affordable and fairer. The council shall be involved in the |
22 | planning and conduct of the quarterly public meetings in accordance with subsection (a) above. |
23 | The advisory council shall develop measures to inform small businesses of an insurance |
24 | complaint process to ensure that small businesses that experience rate increases in a given year |
25 | may request and receive a formal review by the department. The advisory council shall assess |
26 | views of the health provider community relative to insurance rates of reimbursement, billing and |
27 | reimbursement procedures, and the insurers' role in promoting efficient and high quality health |
28 | care. The advisory council shall issue an annual report of findings and recommendations to the |
29 | governor and the general assembly and present their findings at hearings before the house and |
30 | senate finance committees. The advisory council is to be diverse in interests and shall include |
31 | representatives of community consumer organizations; small businesses, other than those |
32 | involved in the sale of insurance products; and hospital, medical, and other health provider |
33 | organizations. Such representatives shall be nominated by their respective organizations. The |
34 | advisory council shall be co-chaired by the health insurance commissioner and a community |
| LC005176 - Page 4 of 10 |
1 | consumer organization or small business member to be elected by the full advisory council. |
2 | (d) To establish and provide guidance and assistance to a subcommittee ("The |
3 | Professional Provider-Health Plan Work Group") of the advisory council created pursuant to |
4 | subsection (c) above, composed of health care providers and Rhode Island licensed health plans. |
5 | This subcommittee shall include in its annual report and presentation before the house and senate |
6 | finance committees the following information: |
7 | (1) A method whereby health plans shall disclose to contracted providers the fee |
8 | schedules used to provide payment to those providers for services rendered to covered patients; |
9 | (2) A standardized provider application and credentials verification process, for the |
10 | purpose of verifying professional qualifications of participating health care providers; |
11 | (3) The uniform health plan claim form utilized by participating providers; |
12 | (4) Methods for health maintenance organizations as defined by section 27-41-1, and |
13 | nonprofit hospital or medical service corporations as defined by chapters 27-19 and 27-20, to |
14 | make facility-specific data and other medical service-specific data available in reasonably |
15 | consistent formats to patients regarding quality and costs. This information would help consumers |
16 | make informed choices regarding the facilities and/or clinicians or physician practices at which to |
17 | seek care. Among the items considered would be the unique health services and other public |
18 | goods provided by facilities and/or clinicians or physician practices in establishing the most |
19 | appropriate cost comparisons; |
20 | (5) All activities related to contractual disclosure to participating providers of the |
21 | mechanisms for resolving health plan/provider disputes; |
22 | (6) The uniform process being utilized for confirming in real time patient insurance |
23 | enrollment status, benefits coverage, including co-pays and deductibles; |
24 | (7) Information related to temporary credentialing of providers seeking to participate in |
25 | the plan's network and the impact of said activity on health plan accreditation; |
26 | (8) The feasibility of regular contract renegotiations between plans and the providers in |
27 | their networks; and |
28 | (9) Efforts conducted related to reviewing impact of silent PPOs on physician practices. |
29 | (e) To enforce the provisions of Title 27 and Title 42 as set forth in section 42-14-5(d). |
30 | (f) To provide analysis of the Rhode Island Affordable Health Plan Reinsurance Fund. |
31 | The fund shall be used to effectuate the provisions of sections 27-18.5-8 and 27-50-17. |
32 | (g) To analyze the impact of changing the rating guidelines and/or merging the |
33 | individual health insurance market as defined in chapter 27-18.5 and the small employer health |
34 | insurance market as defined in chapter 27-50 in accordance with the following: |
| LC005176 - Page 5 of 10 |
1 | (1) The analysis shall forecast the likely rate increases required to effect the changes |
2 | recommended pursuant to the preceding subsection (g) in the direct pay market and small |
3 | employer health insurance market over the next five (5) years, based on the current rating |
4 | structure, and current products. |
5 | (2) The analysis shall include examining the impact of merging the individual and small |
6 | employer markets on premiums charged to individuals and small employer groups. |
7 | (3) The analysis shall include examining the impact on rates in each of the individual and |
8 | small employer health insurance markets and the number of insureds in the context of possible |
9 | changes to the rating guidelines used for small employer groups, including: community rating |
10 | principles; expanding small employer rate bonds beyond the current range; increasing the |
11 | employer group size in the small group market; and/or adding rating factors for broker and/or |
12 | tobacco use. |
13 | (4) The analysis shall include examining the adequacy of current statutory and regulatory |
14 | oversight of the rating process and factors employed by the participants in the proposed new |
15 | merged market. |
16 | (5) The analysis shall include assessment of possible reinsurance mechanisms and/or |
17 | federal high-risk pool structures and funding to support the health insurance market in Rhode |
18 | Island by reducing the risk of adverse selection and the incremental insurance premiums charged |
19 | for this risk, and/or by making health insurance affordable for a selected at-risk population. |
20 | (6) The health insurance commissioner shall work with an insurance market merger task |
21 | force to assist with the analysis. The task force shall be chaired by the health insurance |
22 | commissioner and shall include, but not be limited to, representatives of the general assembly, the |
23 | business community, small employer carriers as defined in section 27-50-3, carriers offering |
24 | coverage in the individual market in Rhode Island, health insurance brokers and members of the |
25 | general public. |
26 | (7) For the purposes of conducting this analysis, the commissioner may contract with an |
27 | outside organization with expertise in fiscal analysis of the private insurance market. In |
28 | conducting its study, the organization shall, to the extent possible, obtain and use actual health |
29 | plan data. Said data shall be subject to state and federal laws and regulations governing |
30 | confidentiality of health care and proprietary information. |
31 | (8) The task force shall meet as necessary and include their findings in the annual report |
32 | and the commissioner shall include the information in the annual presentation before the house |
33 | and senate finance committees. |
34 | (h) To establish and convene a workgroup representing health care providers and health |
| LC005176 - Page 6 of 10 |
1 | insurers for the purpose of coordinating the development of processes, guidelines, and standards |
2 | to streamline health care administration that are to be adopted by payors and providers of health |
3 | care services operating in the state. This workgroup shall include representatives with expertise |
4 | that would contribute to the streamlining of health care administration and that are selected from |
5 | hospitals, physician practices, community behavioral health organizations, each health insurer |
6 | and other affected entities. The workgroup shall also include at least one designee each from the |
7 | Rhode Island Medical Society, Rhode Island Council of Community Mental Health |
8 | Organizations, the Rhode Island Health Center Association, and the Hospital Association of |
9 | Rhode Island. The workgroup shall consider and make recommendations for: |
10 | (1) Establishing a consistent standard for electronic eligibility and coverage verification. |
11 | Such standard shall: |
12 | (i) Include standards for eligibility inquiry and response and, wherever possible, be |
13 | consistent with the standards adopted by nationally recognized organizations, such as the centers |
14 | for Medicare and Medicaid services; |
15 | (ii) Enable providers and payors to exchange eligibility requests and responses on a |
16 | system-to-system basis or using a payor supported web browser; |
17 | (iii) Provide reasonably detailed information on a consumer's eligibility for health care |
18 | coverage, scope of benefits, limitations and exclusions provided under that coverage, cost-sharing |
19 | requirements for specific services at the specific time of the inquiry, current deductible amounts, |
20 | accumulated or limited benefits, out-of-pocket maximums, any maximum policy amounts, and |
21 | other information required for the provider to collect the patient's portion of the bill; |
22 | (iv) Reflect the necessary limitations imposed on payors by the originator of the |
23 | eligibility and benefits information; |
24 | (v) Recommend a standard or common process to protect all providers from the costs of |
25 | services to patients who are ineligible for insurance coverage in circumstances where a payor |
26 | provides eligibility verification based on best information available to the payor at the date of the |
27 | request of eligibility. |
28 | (2) Developing implementation guidelines and promoting adoption of such guidelines |
29 | for: |
30 | (i) The use of the national correct coding initiative code edit policy by payors and |
31 | providers in the state; |
32 | (ii) Publishing any variations from codes and mutually exclusive codes by payors in a |
33 | manner that makes for simple retrieval and implementation by providers; |
34 | (iii) Use of health insurance portability and accountability act standard group codes, |
| LC005176 - Page 7 of 10 |
1 | reason codes, and remark codes by payors in electronic remittances sent to providers; |
2 | (iv) The processing of corrections to claims by providers and payors. |
3 | (v) A standard payor denial review process for providers when they request a |
4 | reconsideration of a denial of a claim that results from differences in clinical edits where no |
5 | single, common standards body or process exists and multiple conflicting sources are in use by |
6 | payors and providers. |
7 | (vi) Nothing in this section or in the guidelines developed shall inhibit an individual |
8 | payor's ability to employ, and not disclose to providers, temporary code edits for the purpose of |
9 | detecting and deterring fraudulent billing activities. The guidelines shall require that each payor |
10 | disclose to the provider its adjudication decision on a claim that was denied or adjusted based on |
11 | the application of such edits and that the provider have access to the payor's review and appeal |
12 | process to challenge the payor's adjudication decision. |
13 | (vii) Nothing in this subsection shall be construed to modify the rights or obligations of |
14 | payors or providers with respect to procedures relating to the investigation, reporting, appeal, or |
15 | prosecution under applicable law of potentially fraudulent billing activities. |
16 | (3) Developing and promoting widespread adoption by payors and providers of |
17 | guidelines to: |
18 | (i) Ensure payors do not automatically deny claims for services when extenuating |
19 | circumstances make it impossible for the provider to obtain a preauthorization before services are |
20 | performed or notify a payor within an appropriate standardized timeline of a patient's admission; |
21 | (ii) Require payors to use common and consistent processes and time frames when |
22 | responding to provider requests for medical management approvals. Whenever possible, such |
23 | time frames shall be consistent with those established by leading national organizations and be |
24 | based upon the acuity of the patient's need for care or treatment. For the purposes of this section, |
25 | medical management includes prior authorization of services, preauthorization of services, |
26 | precertification of services, post service review, medical necessity review, and benefits advisory; |
27 | (iii) Develop, maintain, and promote widespread adoption of a single common website |
28 | where providers can obtain payors' preauthorization, benefits advisory, and preadmission |
29 | requirements; |
30 | (iv) Establish guidelines for payors to develop and maintain a website that providers can |
31 | use to request a preauthorization, including a prospective clinical necessity review; receive an |
32 | authorization number; and transmit an admission notification. |
33 | (i) To issue an ANTI-CANCER MEDICATION REPORT. - Not later than June 30, |
34 | 2014 and annually thereafter, the office of the health insurance commissioner (OHIC) shall |
| LC005176 - Page 8 of 10 |
1 | provide the senate committee on health and human services, and the house committee on |
2 | corporations, with: (1) Information on the availability in the commercial market of coverage for |
3 | anti-cancer medication options; (2) For the state employee's health benefit plan, the costs of |
4 | various cancer treatment options; (3) The changes in drug prices over the prior thirty-six (36) |
5 | months; and (4) Member utilization and cost-sharing expense. |
6 | (j) To monitor the adequacy of each health plan's compliance with the provisions of the |
7 | federal mental health parity act, including a review of related claims processing and |
8 | reimbursement procedures. Findings, recommendations and assessments shall be made available |
9 | to the public. |
10 | (k) To monitor the transition from fee for service and toward global and other alternative |
11 | payment methodologies for the payment for healthcare services. Alternative payment |
12 | methodologies should be assessed for their likelihood to promote access to affordable health |
13 | insurance, health outcomes and performance. |
14 | (l) To report annually, no later than July 1, 2014, then biannually thereafter, on hospital |
15 | payment variation, including findings and recommendations, subject to available resources. |
16 | (m) Notwithstanding any provision of the general or public laws or regulation to the |
17 | contrary, provide a report with findings and recommendations to the president of the senate and |
18 | the speaker of the house, on or before April 1, 2014, including, but not limited to, the following |
19 | information: |
20 | (1) The impact of the current mandated healthcare benefits as defined in sections 27-18- |
21 | 48.1, 27-18-60, 27-18-62, 27-18-64, similar provisions in title 27, chapters 19, 20 and 41, and |
22 | subsection 27-18-3(c), 27-38.2-1 et seq., or others as determined by the commissioner, on the cost |
23 | of health insurance for fully insured employers, subject to available resources; |
24 | (2) Current provider and insurer mandates that are unnecessary and/or duplicative due to |
25 | the existing standards of care and/or delivery of services in the healthcare system; |
26 | (3) A state-by-state comparison of health insurance mandates and the extent to which |
27 | Rhode Island mandates exceed other states benefits; and |
28 | (4) Recommendations for amendments to existing mandated benefits based on the |
29 | findings in (1), (2) and (3) above. |
30 | (n) On or before July 1, 2014, the office of the health insurance commissioner in |
31 | collaboration with the director of health and lieutenant governor's office shall submit a report to |
32 | the general assembly and the governor to inform the design of accountable care organizations |
33 | (ACOs) in Rhode Island as unique structures for comprehensive healthcare delivery and value |
34 | based payment arrangements, that shall include, but not limited to: |
| LC005176 - Page 9 of 10 |
1 | (1) Utilization review; |
2 | (2) Contracting; and |
3 | (3) Licensing and regulation. |
4 | (o) On or before October 1, 2015, and annually thereafter, the health insurance |
5 | commissioner shall also assess the adequacy of each health plan's compliance with the provisions |
6 | of § 27-38.2-1 regarding mental illness and medication assisted treatment coverage. |
7 | (p) On or before October 1, 2015, and annually thereafter, the department of health shall |
8 | also assess the adequacy of those discharge plans and transition processes developed by hospitals, |
9 | health care clinics, urgent care centers, and emergency room diversion facilities for patients with |
10 | opioid and other substance use disorders pursuant to the provisions of § 23-17.26-3. |
11 | SECTION 4. Sunset provision. On or before November 1, 2017, the department of health |
12 | and the health insurance commissioner shall submit to the governor, the speaker of the house and |
13 | the president of the senate, recommendations as to the continuation of requirements of the special |
14 | discharge plan and transition process requirements for patients with opioid and other substance |
15 | use disorders as required in this act. Unless extended by the general assembly, the obligation to |
16 | establish, implement and continue such a special discharge plan and transition process will cease |
17 | on March 1, 2018. |
18 | SECTION 5. This act shall take effect on October 1, 2014, and shall be repealed on |
19 | March 1, 2018. |
======== | |
LC005176 | |
======== | |
| LC005176 - Page 10 of 10 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE - INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE USE DISORDERS | |
*** | |
1 | This act would require mandatory health insurance coverage for certain listed drugs |
2 | which treat opioid substance use disorders. This act would also require hospitals, health care |
3 | clinics, urgent care centers and emergency room diversion facilities to amend their discharge |
4 | plans and transition processes to address patients with opioid and other substance use disorders. |
5 | The act would require at least one follow-up contact by the hospital, health care clinic, urgent |
6 | care center or emergency room diversion facility with the patient after discharge, and the |
7 | scheduling of at least one follow-up appointment with an appropriate facility for the patient. The |
8 | health insurance commissioner would annually review the adequacy of each health insurer's |
9 | coverage and the department of health would assess the adequacy of the discharge plans and |
10 | transition processes developed by health care facilities. |
11 | This act would take effect on October 1, 2014, and would be repealed on March 1, 2018. |
======== | |
LC005176 | |
======== | |
| LC005176 - Page 11 of 10 |